Bid document



SUBJECT*

NEW – STX Specialized Molecular Residual Disease Testing

GENERAL INFORMATION

CONTRACTING OFFICE’S ZIP CODE*

78240

SOLICITATION NUMBER*

36C25727Q0058

RESPONSE DATE/TIME/ZONE

10-30-2026 10AM CENTRAL TIME, CHICAGO, USA

ARCHIVE

60 DAYS AFTER THE RESPONSE DATE

RECOVERY ACT FUNDS

N

PRODUCT SERVICE CODE*

Q301

NAICS CODE*

621511

CONTRACTING OFFICE ADDRESS

Department Of Veterans Affairs
Network Contracting Office 17

5441 Babcock Road Ste. 302
San Antonio TX 78240

POINT OF CONTACT*

Contract Specialist
Susan Flores
[email protected]
(210) 694-6227

ADDITIONAL INFORMATION

AGENCY’S URL

URL DESCRIPTION

AGENCY CONTACT’S EMAIL ADDRESS

EMAIL DESCRIPTION

DESCRIPTION

1. NOTICE OF INTENT DESCRIPTION

The Department of Veterans Affairs, Network Contracting Office (NCO) 17, located at 5441 Babcock Road, Suite 302, San Antonio, TX 78229, intends to award an Indefinite Delivery Indefinite Quantity (IDIQ) FirmFixedPrice contract with five ordering periods on a sole-source basis to: Natera, Inc.13011 McCallen PassAustin, TX 78752
This requirement is for proprietary molecular genetic reference testing services used in the evaluation and monitoring of transplant patients and cancer residual disease.

2. SUPPLIES/SERVICES

Item 0001Description: Signatera Only, CPT Codes 81479, 81455Estimated Quantity: 35Unit: Each Item 0002Description: Prospera, CPT Code 81479Estimated Quantity: 25Unit: Each Natera is the sole provider of these proprietary medical laboratory tests, including:• Prospera molecular expression transplant assessment test• Signatera Residual Disease Test (MRD) (non–liquid biopsy tumor typing) No other vendor possesses the proprietary methodologies, assays, or intellectual property required to perform these tests.

3. SOLE SOURCE JUSTIFICATION

Testing required by the VA is proprietary to Natera, Inc. No authorized distributors, thirdparty laboratories, or alternative clinical sources exist for the Prospera and Signatera MRD tests. These assays cannot be substituted or performed by any other laboratory. Only Natera maintains the necessary technology, reagents, and bioinformatics platforms.

4. THIS NOTICE IS NOT A REQUEST FOR QUOTES

This Special Notice is issued solely for information and planning purposes. It does not constitute a solicitation or a request for competitive quotes. Interested parties may submit a capability statement demonstrating an ability to perform the required testing. Responses must clearly show that an equivalent proprietary test exists and can be provided.

5. RESPONSE INSTRUCTIONS